dc.contributor.author | Fawsitt, CG | en_US |
dc.contributor.author | Vickerman, P | en_US |
dc.contributor.author | Cooke, G | en_US |
dc.contributor.author | Welton, NJ | en_US |
dc.contributor.author | Barnes, E | en_US |
dc.contributor.author | Ball, J | en_US |
dc.contributor.author | Brainard, D | en_US |
dc.contributor.author | Burgess, G | en_US |
dc.contributor.author | Cooke, G | en_US |
dc.contributor.author | Dillon, J | en_US |
dc.contributor.author | Foster, G | en_US |
dc.contributor.author | Gore, C | en_US |
dc.contributor.author | Guha, N | en_US |
dc.contributor.author | Halford, R | en_US |
dc.contributor.author | Whitby, K | en_US |
dc.contributor.author | Holmes, C | en_US |
dc.contributor.author | Howe, A | en_US |
dc.contributor.author | Hudson, E | en_US |
dc.contributor.author | Hutchinson, S | en_US |
dc.contributor.author | Irving, W | en_US |
dc.contributor.author | Khakoo, S | en_US |
dc.contributor.author | Klenerman, P | en_US |
dc.contributor.author | Martin, N | en_US |
dc.contributor.author | Massetto, B | en_US |
dc.contributor.author | Mbisa, T | en_US |
dc.contributor.author | McHutchison, J | en_US |
dc.contributor.author | McKeating, J | en_US |
dc.contributor.author | McLauchlan, J | en_US |
dc.contributor.author | Miners, A | en_US |
dc.contributor.author | Murray, A | en_US |
dc.contributor.author | Shaw, P | en_US |
dc.contributor.author | Simmonds, P | en_US |
dc.contributor.author | Spencer, C | en_US |
dc.contributor.author | Thomson, E | en_US |
dc.contributor.author | Vickerman, P | en_US |
dc.contributor.author | Zitzmann, N | en_US |
dc.contributor.author | Consortium, STOP-HCV | en_US |
dc.date.accessioned | 2020-06-16T09:52:32Z | |
dc.date.available | 2018-12-29 | en_US |
dc.date.issued | 2019-06 | en_US |
dc.identifier.issn | 1098-3015 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/64995 | |
dc.format.extent | 693 - 703 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | VALUE IN HEALTH | en_US |
dc.rights | CC BY license | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | cost-effectiveness | en_US |
dc.subject | direct-acting antivirals | en_US |
dc.subject | hepatitis C virus | en_US |
dc.subject | shortened treatment duration | en_US |
dc.title | A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1016/j.jval.2018.12.011 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000470966200011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 6 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 22 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |